BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23790)

  • 1. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P; Singer E; Kraupp O
    Arzneimittelforschung; 1977; 27(11):2063-6. PubMed ID: 23790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J; Härtfelder G; Lindner E; Schölkens B
    Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats].
    Pape D; Lacroix P; Linée P; Le Pollés JB; Van den Driessche J
    C R Seances Soc Biol Fil; 1977; 171(1):224-8. PubMed ID: 20200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA; Robson RD; Share NN
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of beta-blocking activity of low-dose bupranolol.
    Weisser B; Noack E; Düsing R; Glänzer K
    Int J Clin Pharmacol Res; 1989; 9(1):9-14. PubMed ID: 2565296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.
    Weber MA; Thornell IR; Stokes GS
    J Pharmacol Exp Ther; 1974 Jan; 188(1):234-40. PubMed ID: 4148935
    [No Abstract]   [Full Text] [Related]  

  • 10. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit.
    Weber MA; Oates HF; Stokes GS
    Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity (author's transl)].
    Bentue-Ferrer D; Allain H; Van den Driessche J; Pape D; Reymann JM
    J Pharmacol; 1981; 12(2):161-77. PubMed ID: 6115097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective and non-selective beta 1-blockade on renin secretion in the isolated rat kidney.
    Haro JM; Vargas F; Castillo MA; García-Torres L; Acuña D
    Rev Esp Fisiol; 1989 Jun; 45(2):195-8. PubMed ID: 2570449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of renin release by timolol.
    Graham RM; Oates HF; Weber MA; Stokes GS
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):205-10. PubMed ID: 5974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W; Shibasaki K; Matsuda Y; Asano M; Takenaka T
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 17. Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
    Bartsch W; Sponer G; Dietmann K
    Arzneimittelforschung; 1977; 27(12):2319-22. PubMed ID: 23798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U; Nürnberger H; Femmer K
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of propranolol and ICI 66082 in blocking the renin releasing effect of renal nerve stimulation in the cat.
    Johns EJ; Singer B
    Br J Pharmacol; 1974 Oct; 52(2):315-8. PubMed ID: 4155994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.